Plain-language summary: Tesamorelin is a synthetic growth-hormone-releasing factor analogue and the active ingredient in FDA-approved prescription products for one specific use. That approval does not apply to generic research vials, other formulations, or weight-loss claims.
What Is Tesamorelin Peptide?
Tesamorelin is a peptide analogue of growth-hormone-releasing factor. It stimulates the pituitary growth-hormone pathway and affects IGF-1. In the United States, product-specific approval applies to EGRIFTA formulations and their official labeling—not to every item sold under the tesamorelin name.
FDA-Approved Use and Important Limits
FDA-approved EGRIFTA SV labeling identifies tesamorelin for reducing excess abdominal fat in adults with HIV and lipodystrophy. The label states that it is not indicated for weight-loss management and that long-term cardiovascular safety has not been established. Product formulation matters because reconstitution information is specific to the approved product and vial strength.
Tesamorelin Calculator and Reconstitution Math
The Tesamorelin calculator performs generic concentration and unit-conversion math from a user-entered vial amount, BAC Water (Bacteriostatic Water) volume, and required target amount. It can display mg, mcg, mL, and a corresponding syringe-scale position. It does not reproduce product instructions, select a dose, or replace official labeling.
Tesamorelin Dosage and Dosage-Chart Searches
Dosage searches often mix an approved prescription product with generic vials, alternate strengths, or weight-loss marketing. Those are not interchangeable. This page does not provide a dosage chart or personalized instructions; approved-product questions belong with the current FDA labeling and a licensed clinician or pharmacist.
Tesamorelin Benefits, Results, and Side Effects
Clinical evidence supports the approved product’s narrow indication, not broad fat-loss, bodybuilding, or anti-aging claims. FDA labeling includes important contraindications and warnings involving malignancy risk, elevated IGF-1, fluid retention, glucose intolerance or diabetes, hypersensitivity, and injection-site reactions.
Tesamorelin and Ipamorelin
Tesamorelin and ipamorelin are distinct compounds. Online blend searches do not establish that a combination is FDA approved, standardized, safe, or supported by controlled clinical evidence.
Frequently Asked Questions
Is Tesamorelin FDA approved?
Tesamorelin is the active ingredient in specific FDA-approved EGRIFTA prescription products. Approval is limited to those products, formulations, labeling, and indication; it does not validate generic research vials.
Is Tesamorelin approved for weight loss?
No. FDA-approved labeling states that EGRIFTA SV is not indicated for weight-loss management.
Does this page provide a Tesamorelin dosage?
No. It performs math only with quantities entered by the visitor. It does not recommend a dose, daily schedule, cycle, route, or treatment.
Why is formulation important?
Approved-product instructions can differ by formulation and vial strength. A generic calculator cannot determine whether a vial matches an approved product or its official instructions.
